Recent studies have shone that a molecule comparable with resveratrol could stand for a treatment for the worrying weight gain epidemic - pterostilbene and obesity could be the answer scientists have been looking for in the subject.

A compound found in grapes and blueberries may be the answer behind future treatments for obesity, according to a new study in the University of the Basque Country. In the new research, scientists have found that pterostilbene's obesity results show that, in animals, this natural compound helps reduce the build-up of body fat.

According to an investigation performed by researchers of the "Nutrition and Obesity" group at UPV/EHU (part of the Spanish Biomedical Research Centre in Physiopathology of Obesity and Nutrition of the Carlos III Institute of Health) in accordance with the United States Department of Agriculture, a new pterostilbene and obesity trait has been found, as researchers discovered that it could lead to new treatments.

The pterostilbene obesity research was focused on seeing what type of effects this compound would have in animals, particularly rats. The study, called "Pterostilbene, a Dimethyl Ether Derivative of Resveratrol, Reduces Fat Accumulation in Rats Fed an Obesogenic Diet" and published recently, shows that there is indeed a correlation between this compound and weight loss, as had been suggested before.

For years, the consumption of products such as red wine and blueberries has been seen as a part of a healthy diet due to their anti-oxidant compounds, but according to Science Daily, the new study results are actually quite promising. They've resulted in a patent, and could lead up to new treatment to lower body mass in people suffering from obesity.

For now, pterostilbene for obesity has only been tested in animals, and trials with human subjects are still to be seen, though the team of researchers is definitely looking forward into extending the investigations.